These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9366297)

  • 1. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast.
    Guidi AJ; Schnitt SJ; Fischer L; Tognazzi K; Harris JR; Dvorak HF; Brown LF
    Cancer; 1997 Nov; 80(10):1945-53. PubMed ID: 9366297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.
    Brown LF; Berse B; Jackman RW; Tognazzi K; Guidi AJ; Dvorak HF; Senger DR; Connolly JL; Schnitt SJ
    Hum Pathol; 1995 Jan; 26(1):86-91. PubMed ID: 7821921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
    Guidi AJ; Abu-Jawdeh G; Tognazzi K; Dvorak HF; Brown LF
    Cancer; 1996 Aug; 78(3):454-60. PubMed ID: 8697391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
    Lee AH; Dublin EA; Bobrow LG; Poulsom R
    J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radial scars of the breast and breast carcinomas have similar alterations in expression of factors involved in vascular stroma formation.
    Jacobs TW; Schnitt SJ; Tan X; Brown LF
    Hum Pathol; 2002 Jan; 33(1):29-38. PubMed ID: 11823971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma.
    Chhieng DC; Tabbara SO; Marley EF; Talley LI; Frost AR
    Breast J; 2003; 9(3):200-7. PubMed ID: 12752628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia.
    Guidi AJ; Abu-Jawdeh G; Berse B; Jackman RW; Tognazzi K; Dvorak HF; Brown LF
    J Natl Cancer Inst; 1995 Aug; 87(16):1237-45. PubMed ID: 7563170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
    Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia.
    Denhart BC; Guidi AJ; Tognazzi K; Dvorak HF; Brown LF
    Lab Invest; 1997 Dec; 77(6):659-64. PubMed ID: 9426404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvessel density and distribution in ductal carcinoma in situ of the breast.
    Guidi AJ; Fischer L; Harris JR; Schnitt SJ
    J Natl Cancer Inst; 1994 Apr; 86(8):614-9. PubMed ID: 7511693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
    Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers.
    Hieken TJ; Farolan M; D'Alessandro S; Velasco JM
    Surgery; 2001 Oct; 130(4):593-600; discussion 600-1. PubMed ID: 11602889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
    Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
    Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ.
    Wülfing P; Kersting C; Buerger H; Mattsson B; Mesters R; Gustmann C; Hinrichs B; Tio J; Böcker W; Kiesel L
    Br J Cancer; 2005 May; 92(9):1720-8. PubMed ID: 15841074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma.
    Valković T; Dobrila F; Melato M; Sasso F; Rizzardi C; Jonjić N
    Virchows Arch; 2002 Jun; 440(6):583-8. PubMed ID: 12070596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation.
    Ito A; Hirota S; Mizuno H; Kawasaki Y; Takemura T; Nishiura T; Kanakura Y; Katayama Y; Nomura S; Kitamura Y
    Pathol Int; 1995 Oct; 45(10):715-20. PubMed ID: 8563931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.
    Rak J; Mitsuhashi Y; Bayko L; Filmus J; Shirasawa S; Sasazuki T; Kerbel RS
    Cancer Res; 1995 Oct; 55(20):4575-80. PubMed ID: 7553632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor.
    Callagy G; Dimitriadis E; Harmey J; Bouchier-Hayes D; Leader M; Kay E
    Appl Immunohistochem Mol Morphol; 2000 Jun; 8(2):104-9. PubMed ID: 10937057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.